Glioblastoma shortly after a normal conventional brain magnetic resonance imaging: A report of two cases and review of the literature

Glioblastoma (GB) is the most common malignant tumor of the brain. Most of these tumors are primary or de novo GBs that manifest rapidly with initial presentations such as headache, new-onset epileptic seizure, focal neurological deficits, and altered mental status. The typical radiological features of GB include strong contrast enhancement, central necrosis, and edema with mass effect. Herein, we describe two cases of primary GB – two women aged 60 and 51 years who were diagnosed with GB 3.5 and 4 months, respectively, after their initial admission. These patients presented with right-sided headaches, and their neurological examination was within the normal limits. Their initial radiological investigations revealed no suspicious lesions, either on T1-weighted or T2-weighted magnetic resonance (MR) images. The 60-year-old patient was readmitted with persistent headache, and her T1-weighted MR images revealed a well-demarcated mass lesion in the right temporal lobe with strong contrast enhancement. Moreover, the T2-weighted MR images revealed closed sulci and swollen midline structures because of edema. The 51-year-old patient was readmitted with persistent headache, and her MR image revealed a mass lesion with heterogeneous contrast enhancement and necrosis on T1-weighted images and hyperintense areas with severe edema on T2-weighted images. The patients underwent craniotomy and gross total tumor resection. Notably, in both cases, the lesions were pathologically diagnosed as GB. Therefore, it should be borne in mind that only persistent headache could be a sentinel sign of GB before it becomes radiologically visible, thereby emphasizing the need for follow-up imaging studies at short intervals.

Key-words:

Cerebral imaging - diagnosis - glioblastoma - headache - magnetic resonance imaging - occult brain tumor

Financial support and sponsorship

Nil.

Publikationsverlauf

Eingereicht: 23. Dezember 2020

Angenommen: 13. März 2021

Artikel online veröffentlicht:
16. August 2022

• References

• 1 Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007;170:1445-53.
• 2 Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol 2017;18:e315-29.
• 3 Toh CH, Castillo M. Early-stage glioblastomas: MR imaging-based classification and imaging evidence of progressive growth. AJNR Am J Neuroradiol 2017;38:288-93.
• 4 Chittiboina P, Connor DE, Caldito G, Quillin JW, Wilson JD, Nanda A. Occult tumors presenting with negative imaging: Analysis of the literature: A review. J Neurosurg 2021;116:1195-203.
• 5 Schröter N, Lützen N, Doostkam S, Berger B. Glioblastoma evolving within 10 days following unremarkable computer tomography of the brain: A case report. Int J Neurosci 2020:1-4. doi: 10.1080/00207454.2020.1753730.
• 6 Khalatbari MR, Hamidi M, Moharamzad Y. Glioblastoma multiforme with very rapid growth and long-term survival in children: Report of two cases and review of the literature. Childs Nerv Syst 2011;27:1347-52.
• 7 Thaler PB, Li JY, Isakov Y, Black KS, Schulder M, Demopoulos A. Normal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors. J Clin Neurosci 2012;19:411-4.
• 8 Bolender NF, Cromwell LD, Graves V, Margolis MT, Kerber CW, Wendling L. Interval appearance of glioblastomas not evident in previous CT examinations. J Comput Assist Tomogr 1983;7:599-603.
• 9 Hylton PD, Reichman OH. Clinical manifestation of glioma before computed tomographic appearance: The dilemma of a negative scan. Neurosurgery 1987;21:27-32.
• 10 Tentler RL, Palacios E. False-negative computerized tomography in brain tumor. JAMA 1977;238:339-40.
• 11 Wang H, Liu Z, Zhang Y, Hou F, Fu W, Lin J, et al. Additional diagnostic value of unenhanced computed tomography plus diffusion-weighted imaging combined with routine magnetic resonance imaging findings of early-stage gliblastoma. Biomed Res Int 2020;2020:1672736.
• 12 Okamoto K, Ito J, Takahashi N, Ishikawa K, Furusawa T, Tokiguchi S, et al. MRI of high-grade astrocytic tumors: Early appearance and evolution. Neuroradiology 2002;44:395-402.
• 13 Ideguchi M, Kajiwara K, Goto H, Sugimoto K, Nomura S, Ikeda E, et al. MRI findings and pathological features in early-stage glioblastoma. J Neurooncol 2015;123:289-97.
• 14 Oyama H, Ando Y, Aoki S, Kito A, Maki H, Hattori K, et al. Glioblastoma detected at the initial stage in its developmental process - Case report. Neurol Med Chir (Tokyo) 2010;50:414-7.
• 15 Baehring JM, Bi WL, Bannykh S, Piepmeier JM, Fulbright RK. Diffusion MRI in the early diagnosis of malignant glioma. J Neurooncol 2007;82:221-5.
• 16 Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, et al. Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 2020;22:1073-113.
• 17 Hishii M, Matsumoto T, Arai H. Diagnosis and treatment of early-stage glioblastoma. Asian J Neurosurg 2019;14:589-92.
• 18 Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115:3-8.